229 related articles for article (PubMed ID: 15645491)
21. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent.
Centurion SA; Kuo HR; Lambert WC
Exp Cell Res; 2000 Nov; 260(2):216-21. PubMed ID: 11035916
[TBL] [Abstract][Full Text] [Related]
22. Fanconi anemia C protein acts at a switch between apoptosis and necrosis in mitomycin C-induced cell death.
Guillouf C; Wang TS; Liu J; Walsh CE; Poirier GG; Moustacchi E; Rosselli F
Exp Cell Res; 1999 Feb; 246(2):384-94. PubMed ID: 9925754
[TBL] [Abstract][Full Text] [Related]
23. No evidence of significant silencing of Fanconi genes FANCF and FANCB or Nijmegen breakage syndrome gene NBS1 by DNA hyper-methylation in sporadic childhood leukaemia.
Meyer S; White DJ; Will AM; Eden T; Sim A; Brown R; Strathdee G
Br J Haematol; 2006 Jul; 134(1):61-3. PubMed ID: 16803569
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer.
Pejovic T; Yates JE; Liu HY; Hays LE; Akkari Y; Torimaru Y; Keeble W; Rathbun RK; Rodgers WH; Bale AE; Ameziane N; Zwaan CM; Errami A; Thuillier P; Cappuccini F; Olson SB; Cain JM; Bagby GC
Cancer Res; 2006 Sep; 66(18):9017-25. PubMed ID: 16982743
[TBL] [Abstract][Full Text] [Related]
25. The clinical and biological overlap between Nijmegen Breakage Syndrome and Fanconi anemia.
Gennery AR; Slatter MA; Bhattacharya A; Barge D; Haigh S; O'Driscoll M; Coleman R; Abinun M; Flood TJ; Cant AJ; Jeggo PA
Clin Immunol; 2004 Nov; 113(2):214-9. PubMed ID: 15451479
[TBL] [Abstract][Full Text] [Related]
26. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
[TBL] [Abstract][Full Text] [Related]
27. [Complex role of the FA proteins in providing genome stability].
Kluzek K; Zdzienicka MZ
Postepy Biochem; 2005; 51(4):387-94. PubMed ID: 16676573
[TBL] [Abstract][Full Text] [Related]
28. Intracellular localization of the Fanconi anemia complementation group A protein.
Walsh CE; Yountz MR; Simpson DA
Biochem Biophys Res Commun; 1999 Jun; 259(3):594-9. PubMed ID: 10364463
[TBL] [Abstract][Full Text] [Related]
29. Fanconi anaemia genes and susceptibility to cancer.
Mathew CG
Oncogene; 2006 Sep; 25(43):5875-84. PubMed ID: 16998502
[TBL] [Abstract][Full Text] [Related]
30. Spectrum of FANCA mutations in Italian Fanconi anemia patients: identification of six novel alleles and phenotypic characterization of the S858R variant.
Savino M; Borriello A; D'Apolito M; Criscuolo M; Del Vecchio M; Bianco AM; Di Perna M; Calzone R; Nobili B; Zatterale A; Zelante L; Joenje H; Della Ragione F; Savoia A
Hum Mutat; 2003 Oct; 22(4):338-9. PubMed ID: 12955722
[TBL] [Abstract][Full Text] [Related]
31. A new complementation group of mitomycin C-hypersensitive Chinese hamster cell mutants that closely resembles the phenotype of fanconi anemia cells.
Telleman P; Overkamp WJ; van Wessel N; Studzian K; Wetselaar L; Natarajan AT; Zdzienicka MZ
Cancer Res; 1995 Aug; 55(15):3412-6. PubMed ID: 7614481
[TBL] [Abstract][Full Text] [Related]
32. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
[TBL] [Abstract][Full Text] [Related]
33. Fanconi anemia gene mutations are not involved in sporadic Wilms tumor.
Adank MA; Segers H; van Mil SE; van Helsdingen YM; Ameziane N; van den Ouweland AM; Wagner A; Meijers-Heijboer H; Kool M; de Kraker J; Waisfisz Q; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2010 Oct; 55(4):742-4. PubMed ID: 20589654
[TBL] [Abstract][Full Text] [Related]
34. Fanconi anemia revisited: old ideas and new advances.
dos Santos CC; Gavish H; Buchwald M
Stem Cells; 1994 Mar; 12(2):142-53. PubMed ID: 8199559
[TBL] [Abstract][Full Text] [Related]
35. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
[TBL] [Abstract][Full Text] [Related]
36. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
37. Fanconi anaemia and leukaemia - clinical and molecular aspects.
Tischkowitz M; Dokal I
Br J Haematol; 2004 Jul; 126(2):176-91. PubMed ID: 15238138
[TBL] [Abstract][Full Text] [Related]
38. Heterozygous mutations in the PALB2 hereditary breast cancer predisposition gene impact on the three-dimensional nuclear organization of patient-derived cell lines.
Wark L; Novak D; Sabbaghian N; Amrein L; Jangamreddy JR; Cheang M; Pouchet C; Aloyz R; Foulkes WD; Mai S; Tischkowitz M
Genes Chromosomes Cancer; 2013 May; 52(5):480-94. PubMed ID: 23341105
[TBL] [Abstract][Full Text] [Related]
39. Genetic subtyping of Fanconi anemia by comprehensive mutation screening.
Ameziane N; Errami A; Léveillé F; Fontaine C; de Vries Y; van Spaendonk RM; de Winter JP; Pals G; Joenje H
Hum Mutat; 2008 Jan; 29(1):159-66. PubMed ID: 17924555
[TBL] [Abstract][Full Text] [Related]
40. Fanconi anemia: a pleotropic mutation with multiple cellular and developmental abnormalities.
Chaganti RS; Houldsworth J
Ann Genet; 1991; 34(3-4):206-11. PubMed ID: 1809228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
